Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104477 Immunoglobulin library for use in diagnosis, prevention and treatment of autoimmune diseases
06/05/2003US20030104469 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of gastrointestinal, cancer and kidney disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104412 Kit for use in diagnosis and detection of tumors
06/05/2003US20030104402 Methods of producing or identifying intrabodies in eukaryotic cells
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104381 Nucleotide sequences coding polypeptide for use in treatment of heart, cancer and skin disorders
06/05/2003US20030104364 Reagents and methods useful for detecting diseases of the breast
06/05/2003US20030104359 Apparatus for use in the recovery of preferential particles in a sample
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104014 Method for the treatment of malignant and infectious chronic diseases
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030104002 Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins
06/05/2003US20030103997 Can be used to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection
06/05/2003US20030103992 Cadherin-like asymmetry proteins, in particular, polynucleotides, polypeptides, fusion proteins, and antibodies; for modulating immune response
06/05/2003US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
06/05/2003US20030103989 Immunising pregnant mammal with antigen by any two routes of administration selected from intramammary, intraperitoneal and intramuscular and immunising mammal with antigen by third administration route, all three routes being different
06/05/2003US20030103987 Contacting cells of patient with protein having toxic activity of Clostridium sordellii toxin LT under conditions favoring inactivating of Ras by glucosylation of Ras'threonine 35 in cells
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103984 Fusion proteins of biologically active peptides and antibodies
06/05/2003US20030103982 Therapeutic using a bispecific antibody
06/05/2003US20030103980 Glypican-1 in human breast cancer
06/05/2003US20030103979 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103977 Monoclonal antibodies binds to protective epitopes on serotype A, B, C and D strains of Cryptococcal; therapeutic treatment and prevent cryptococcal infection, such as cryptococcal meningitis, in immunosuppressed patients
06/05/2003US20030103976 Anti-fas antibodies
06/05/2003US20030103975 Modulation of angiogenesis and endothelialization
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103971 Immunoregulatory antibodies and uses thereof
06/05/2003US20030103970 Natural human antibody
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103968 Use of alpha specific antibody BIBH1 in the treatment of cancer
06/05/2003US20030103967 Administering an immunomodulator comprising at least one Fc receptor ligand for treating immune disorders such as allergies, transplanted tissue rejection and autoimmune disorders lupus, rheumatoid arthritis and multiple sclerosis
06/05/2003US20030103966 Therapeutic treatment of asthma with anti-allergen antibody
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103962 Methods and compositions for modulating the immune system of animals
06/05/2003US20030103948 Streptavidin expressed gene fusions and methods of use thereof
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103901 ELISA kit for the determination of CYP2C19 metabolic phenotypes and uses thereof
06/05/2003CA2468950A1 Anti-il13 receptor .alpha.1 neutralizing antibody
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468353A1 A novel homeobox gene
06/05/2003CA2468316A1 Novel compositions and methods for cancer
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2467647A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003CA2466931A1 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466615A1 Detection and identification of enteric bacteria
06/05/2003CA2465072A1 Treatment of micro-organism infection
06/04/2003EP1316609A1 Acetoacetyl-CoA thiolase and its use for identifying new fungicidal substances
06/04/2003EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315810A2 Family member of inhibitor of apoptosis proteins
06/04/2003EP1315803A2 Enzymes having high temperature polymerase activity and methods of use thereof
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315753A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315520A2 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
06/04/2003EP1315519A2 Pharmaceutical compositions and methods useful for modulating angiogenesis
06/04/2003EP1315514A2 Methods and compositions for producing a neurosalutary effect in a subject
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1143997B1 Tumor necrosis factor antagonists and their use in endometriosis treatment
06/04/2003EP0749482B1 Recombinant humanized anti-lewis y antibodies
06/04/2003EP0716695B1 Human calcium channel compositions and methods using them
06/04/2003CN1422333A Polypeptide inducing apoptosis
06/04/2003CN1422281A G-protein coupled receptors
06/04/2003CN1421460A Conjugate of lidamycin, monoclonal antibody and its Fab'segment and its application in targeting treatment of colon cancer and other tumors
06/04/2003CN1421459A Humanized CD3-resisting monoclonal antibody
06/04/2003CN1421457A New human protein with cancer cell growth inhibiting function and its coding sequence
06/04/2003CN1110557C LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idio type antibody
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110322C Monoclonal antibody Fab'-pingyangmycin conjugate and its anticancer action
06/03/2003US6573372 Feline immunoglobulin E molecules and compositions there of
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573236 Myelin oligodendrocyte glycoprotein (MOG) polypeptide-specific antibody to bind a natural MOG polypeptide and competitively inhibit the binding of an autoantibody, does not comprise functional Fc portion; multiple sclerosis
06/03/2003US6573098 Nucleic acid libraries
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573094 F-box genes and proteins
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573070 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6573064 Method of screening anti-mycobacterial molecules
06/03/2003US6573062 Method for obtaining modulators of TNF receptor releasing enzyme
1 ... 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 ... 1494